SOURCE: World Street Fundamentals

May 10, 2011 09:00 ET

Global Conditions to Influence Pharmaceuticals -- Industry Report Featuring OXiGENE and Merck & Co., Inc.

HONG KONG--(Marketwire - May 10, 2011) - Today, released its industry report highlighting OXiGENE, Inc. (NASDAQ: OXGN) and Merck & Co., Inc. (NYSE: MRK). Full fundamental and technical analysis is available at

The global pharmaceutical market is expected to experience wide changes, with trends growing towards the Asia-Pacific region. A favorable regulatory environment has started to emerge in India, China, Malaysia, South Korea and Indonesia; drawing the attention of larger API product providers. This new competition within an already fast-paced economy has closed the gap between product cost and disposable income of consumers -- a change that is expected to drive long-term growth within the global marketplace.

Global pharmaceutical market sales are expected to grow at a 4 - 7% compound annual growth rate (CAGR) through 2013, largely driven via growing access to health-care in emerging economic regions. Short-term growth within the sector will be fueled by the US market, as it remains the largest pharmaceutical market in the world. A large focus on R&D in biotechnology, special drugs and generic drugs will remain a strong catalyst to meet 2011 targets of $315 billion dollar in sales volume within the United States alone.

World Street Fundamentals has highlighted OXiGENE for its focus as a clinical-stage, biopharmaceutical company developing therapeutics to treat cancer and eye diseases. OXiGENE's primary focus is the development of product candidates referred to as vascular disrupting agents, (VDAs), that disable and destroy abnormal blood vessels that provide solid tumors a means of growth and survival and also are associated with visual impairment in a number of ophthalmological diseases and conditions. ZYBRESTAT is its lead candidate. The entire report on OXiGENE, Inc. (NASDAQ: OXGN) is available here:

World Street has highlighted Merck & Co. for its health solutions provided through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets through its joint ventures. Merck's operates in four segments: the Pharmaceutical, Animal Health, Consumer Care and Alliances segments. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. The entire report on Merck & Co., Inc. (NYSE: MRK) is available here:

About World Street
World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets around the world. Covering the top performers in the hottest sectors and providing clarity to investors around the world.

Contact Information